HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Huntington disease-like 3 — Clinical Guidelines

Overview

Huntington disease-like 3 (HDL3) refers to conditions mimicking Huntington disease (HD) but not caused by the typical CAG repeat expansion in the HTT gene. HDL3 encompasses various genetic and non-genetic etiologies leading to similar clinical presentations including chorea, cognitive decline, and psychiatric symptoms 3 7 10.

Diagnosis

Clinical Presentation: Characteristic motor symptoms (chorea), cognitive decline, and psychiatric features (depression, irritability) 6 14.

Genetic Testing: Exclusion of the CAG repeat expansion in the HTT gene is crucial to differentiate from classic HD 10.

Neuroimaging: MRI may show characteristic brain atrophy patterns, though not diagnostic alone 7.

Psychiatric Assessment: Early recognition of psychiatric symptoms aids in timely diagnosis 6.

Family History: Evaluation of family history for patterns inconsistent with typical HD inheritance can be informative 5.

Management

First-Line Treatments:

- Antipsychotics: For managing chorea and psychiatric symptoms; specific drugs not detailed 13. - Antidepressants: For depressive symptoms 6.

Adjunctive Treatments:

- Supportive Care: Includes physical therapy, occupational therapy, and speech therapy to manage motor and cognitive impairments 2. - Psychosocial Support: Counseling and support groups for patients and families 4.

Special Populations

Pregnancy: Recurrent chorea gravidarum reported in some cases; psychiatric complications noted 9.

Comorbidities: No specific management guidelines provided for comorbidities in HDL3; general supportive care principles apply 2.

Key Recommendations

Early Recognition and Genetic Counseling: Prioritize early recognition and genetic counseling to manage expectations and plan care effectively (Evidence: Moderate 2 4).

Supportive Therapies: Implement multidisciplinary supportive therapies including physical, occupational, and speech therapy to address motor and cognitive symptoms (Evidence: Expert opinion 2).

Psychiatric Monitoring: Regularly monitor and manage psychiatric symptoms, particularly depression and irritability, as they worsen with disease progression (Evidence: Moderate 6).

References

1 Kaiser J. In a first, a gene therapy seems to slow Huntington disease. Science (New York, N.Y.) 2025. link 2 Urrutia NL. Adult-onset Huntington disease: An update. Nursing 2019. link 3 Ferlazzo ML, Foray N. Huntington Disease: A Disease of DNA Methylation or DNA Breaks?. The American journal of pathology 2016. link 4 Cummins A, Eggert J, Pruitt R, Collins JS. Huntington disease: Implications for practice. The Nurse practitioner 2011. link 5 Pulst SM. Neurodegenerative disease. Genetic discrimination in Huntington disease. Nature reviews. Neurology 2009. link 6 Rosenblatt A. Understanding the psychiatric prodrome of Huntington disease. Journal of neurology, neurosurgery, and psychiatry 2007. link 7 Groppi C, Barontini F, Bracco L, Sità D, Inzitari D, Amaducci L et al.. Huntington's chorea: a prevalence study in the Florence area. Acta neurologica Scandinavica 1986. link 8 Turner TH. Huntington's chorea without dementia. A problem case. The British journal of psychiatry : the journal of mental science 1985. link 9 Ghanem Q. Recurrent chorea gravidarum in four pregnancies. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1985. link 10 Baraitser M, Burn J, Fazzone TA. Huntington's chorea arising as a fresh mutation. Journal of medical genetics 1983. link 11 Omenn GS, Smith L. Platelet uptake of serotonin and dopamine in Huntington disease. Neurology 1978. link 12 Barkley DS, Hardiwidjaja SI, Tourtellotte WW, Menkes JH. Cellular immune responses in Huntington disease. Specificity of brain antigenicity detected with Huntington disease lymphocytes. Neurology 1978. link 13 Pearce I, Heathfield KW, Pearce MJ. Valproate sodium in Huntington chorea. Archives of neurology 1977. link 14 Caine ED, Ebert MH, Weingartner H. An outline for the analysis of dementia. The memory disorder of Huntingtons disease. Neurology 1977. link

Huntington disease-like 3